Success Stories: NAILG Wins NIW for Acting Assistant Professor in Biotechnology—Approval in Less Than 2 Months
Client’s Testimonial:
“What great news! Thank you so much for helping me.”
On April 14th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Acting Assistant Professor in the Field of Biotechnology (Approval Notice).
General Field: Biotechnology
Position at the Time of Case Filing: Acting Assistant Professor
State of Residence at the Time of Filing: Washington
Approval Notice Date: April 14th, 2025
Processing Time: 1 month, 27 days (Premium Processing Requested)
Case Summary:
The North America Immigration Law Group (NAILG) proudly secured a National Interest Waiver (NIW) approval on behalf of a highly accomplished biotechnology researcher whose work is helping to redefine the future of genetic medicine. The client’s proposed endeavor centers on advancing gene and base editing techniques within complex three-dimensional (3D) organoid models—miniature, lab-grown versions of human tissues. This innovative research aims to model genetic diseases with high accuracy, discover new gene-based therapies, engineer functional tissues, and enhance capabilities in organ regeneration and transplantation. These goals are not only scientifically ambitious but nationally significant, as they address urgent healthcare challenges and improve the United States’ ability to treat genetic conditions more effectively and affordably.
NAILG highlighted how this research contributes directly to public health and biomedical innovation in the United States. By enabling more precise study of genetic diseases and therapeutic interventions, the client’s work reduces dependence on less accurate models, shortens the path from discovery to treatment, and enhances long-term outcomes for American patients. The case was particularly strong in demonstrating national importance, despite the absence of recommendation letters, through carefully curated evidence of the client’s contributions and the practical relevance of the proposed work. NAILG framed the endeavor as one of substantial merit with clear and tangible benefits that would be difficult to achieve without the client’s continued presence in the U.S.
To support the petition, the legal team emphasized the client’s strong record of academic productivity and recognition. The petitioner had published eight peer-reviewed journal articles, three of which were first-authored, along with eight abstracts, seven of them also first-authored. The client’s work had already been cited 102 times, underscoring both its scholarly impact and utility within the field. These achievements demonstrated that the petitioner is well-positioned to advance this critical area of research independently. Through a precise and well-supported legal argument, NAILG successfully secured NIW approval, allowing the researcher to continue making meaningful contributions to biomedical science and the national interest in the United States.

